Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Amicus Therapeutics - 12 Year Stock Price History | FOLD

Historical daily share price chart and data for Amicus Therapeutics since 2007 adjusted for splits. The latest closing stock price for Amicus Therapeutics as of April 17, 2019 is 12.87.
  • The all-time high Amicus Therapeutics stock price is 18.23, which is 41.6% above the current share price.
  • The Amicus Therapeutics 52-week high stock price is 17.09, which is 32.8% above the current share price.
  • The Amicus Therapeutics 52-week low stock price is 8.38, which is 34.9% below the current share price.
  • The average Amicus Therapeutics stock price for the last 52 weeks is 13.07.
Amicus Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 12.4980 10.0400 14.4000 10.0400 12.8700 34.34%
2018 13.8221 15.1600 17.1200 8.3800 9.5800 -33.43%
2017 10.3500 5.1300 16.2400 5.1300 14.3900 189.54%
2016 6.9360 9.0300 9.3500 4.5300 4.9700 -48.76%
2015 11.4110 8.6100 18.2300 5.9500 9.7000 16.59%
2014 4.2658 2.4100 8.6100 1.8200 8.3200 254.04%
2013 2.7800 2.8400 4.2200 1.9700 2.3500 -12.31%
2012 5.2648 3.5700 6.8800 2.5300 2.6800 -22.09%
2011 5.3292 4.5600 7.9400 2.1000 3.4400 -26.81%
2010 3.4267 3.8400 4.8000 1.9500 4.7000 18.39%
2009 7.9094 8.0000 12.2700 3.3600 3.9700 -50.25%
2008 11.2884 10.3400 17.9500 7.5000 7.9800 -25.77%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.051B $0.091B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $115.829B 13.05
Gilead Sciences (GILD) United States $82.321B 10.48
Celgene (CELG) United States $66.417B 12.28
Illumina (ILMN) United States $48.412B 57.60
Vertex Pharmaceuticals (VRTX) United States $45.952B 61.56
Biogen (BIIB) United States $44.991B 8.72
Regeneron Pharmaceuticals (REGN) United States $40.180B 18.66
Alexion Pharmaceuticals (ALXN) United States $30.602B 18.97
Incyte (INCY) United States $16.494B 153.96
BioMarin Pharmaceutical (BMRN) United States $15.788B 0.00
Seattle Genetics (SGEN) United States $12.345B 0.00
Exact Sciences (EXAS) United States $11.974B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.414B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
QIAGEN (QGEN) Netherlands $8.959B 29.65
Sarepta Therapeutics (SRPT) United States $8.668B 0.00
Bluebird Bio (BLUE) United States $8.464B 0.00
Moderna (MRNA) United States $7.824B 0.00
BeiGene (BGNE) Cayman Islands $7.681B 0.00
Bio-Techne Corp (TECH) United States $7.375B 49.69
Exelixis (EXEL) United States $6.886B 15.98
Guardant Health (GH) United States $6.584B 0.00
Galapagos (GLPG) Belgium $5.979B 0.00
Amarin (AMRN) Ireland $5.938B 0.00
Alkermes (ALKS) Ireland $5.370B 0.00
Array BioPharma (ARRY) United States $5.119B 0.00
Horizon Pharma Public (HZNP) Ireland $4.727B 14.01
Ascendis Pharma (ASND) Denmark $4.688B 0.00
Spark Therapeutics (ONCE) United States $4.208B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.945B 0.00
China Biologic Products (CBPO) China $3.812B 23.62
ACADIA Pharmaceuticals (ACAD) United States $3.670B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.503B 0.00
Blueprint Medicines (BPMC) United States $3.444B 0.00
Immunomedics (IMMU) United States $3.331B 0.00
Global Blood Therapeutics (GBT) United States $3.285B 0.00
Allogene Therapeutics (ALLO) United States $3.191B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.107B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.741B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.723B 0.00
Emergent Biosolutions (EBS) United States $2.720B 22.62
Akcea Therapeutics (AKCA) United States $2.593B 0.00
Denali Therapeutics (DNLI) United States $2.552B 0.00
Ligand Pharmaceuticals (LGND) United States $2.550B 19.04
Insmed (INSM) United States $2.497B 0.00
Reata Pharmaceuticals (RETA) United States $2.457B 0.00
Repligen (RGEN) United States $2.430B 74.76
Myriad Genetics (MYGN) United States $2.418B 24.63
Halozyme Therapeutics (HALO) United States $2.415B 0.00
Genomic Health (GHDX) United States $2.406B 61.51
Arena Pharmaceuticals (ARNA) United States $2.357B 0.00
Acceleron Pharma (XLRN) United States $2.253B 0.00
Mirati Therapeutics (MRTX) United States $2.248B 0.00
Medicines (MDCO) United States $2.129B 0.00
UniQure (QURE) Netherlands $2.129B 0.00
AnaptysBio (ANAB) United States $2.088B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.043B 0.00
MyoKardia (MYOK) United States $2.007B 0.00
REGENXBIO (RGNX) United States $1.965B 20.41
NeoGenomics (NEO) United States $1.951B 158.69
Nabriva Therapeutics AG (NBRV) Ireland $1.882B 0.00
Audentes Therapeutics (BOLD) United States $1.750B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.736B 0.00
Alector (ALEC) United States $1.715B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.654B 0.00
Atara Biotherapeutics (ATRA) United States $1.647B 0.00
Allakos (ALLK) United States $1.594B 0.00
Rubius Therapeutics (RUBY) United States $1.501B 0.00
Myovant Sciences (MYOV) United Kingdom $1.411B 0.00
Innoviva (INVA) United States $1.393B 3.84
Lion Biotechnologies (IOVA) United States $1.392B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.392B 0.00
Editas Medicine (EDIT) United States $1.336B 0.00
Aimmune Therapeutics (AIMT) United States $1.336B 0.00
Cambrex (CBM) United States $1.324B 14.25
InflaRx (IFRX) Germany $1.313B 0.00
Puma Biotechnology (PBYI) United States $1.304B 0.00
Sangamo Therapeutics (SGMO) United States $1.226B 0.00
Apellis Pharmaceuticals (APLS) United States $1.209B 0.00
Epizyme (EPZM) United States $1.201B 0.00
Gossamer Bio (GOSS) United States $1.146B 0.00
Clovis Oncology (CLVS) United States $1.124B 0.00
Codexis (CDXS) United States $1.115B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.080B 0.00
Fate Therapeutics (FATE) United States $1.073B 0.00
Coherus BioSciences (CHRS) United States $1.046B 0.00
NGM BIOPHARMACT (NGM) United States $1.018B 0.00
Clementia Pharmaceuticals (CMTA) Canada $1.004B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.993B 0.00
Genfit SA (GNFT) France $0.946B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.934B 0.00
RA PHARMCTL INC (RARX) United States $0.925B 0.00
Eidos Therapeutics (EIDX) United States $0.921B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.917B 37.06
Rhythm Pharmaceuticals (RYTM) United States $0.911B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.903B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.898B 0.00
Retrophin (RTRX) United States $0.877B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.843B 0.00
WAVE Life Sciences (WVE) Singapore $0.837B 0.00
Cellectis (CLLS) France $0.832B 0.00
ANI Pharmaceuticals (ANIP) United States $0.813B 14.88
Vericel (VCEL) United States $0.811B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.807B 0.00
Twist Bioscience (TWST) United States $0.789B 0.00
Intellia Therapeutics (NTLA) United States $0.786B 0.00
Athenex (ATNX) United States $0.782B 0.00
Cara Therapeutics (CARA) United States $0.762B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.721B 0.00
Arvinas (ARVN) United States $0.717B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.716B 0.00
Intra-Cellular Therapies (ITCI) United States $0.698B 0.00
Principia Biopharma (PRNB) United States $0.695B 0.00
MeiraGTx Holdings (MGTX) United States $0.670B 0.00
G1 THERAPEUTICS (GTHX) United States $0.664B 0.00
Viking Therapeutics (VKTX) United States $0.658B 0.00
Osiris Therapeutics (OSIR) United States $0.656B 0.00
Precision BioSciences (DTIL) United States $0.650B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.626B 0.00
Revance Therapeutics (RVNC) United States $0.614B 0.00
Stemline Therapeutics (STML) United States $0.610B 0.00
ObsEva SA (OBSV) Switzerland $0.603B 0.00
Synthorx (THOR) United States $0.591B 0.00
Kura Oncology (KURA) United States $0.585B 0.00
Heska (HSKA) United States $0.578B 51.85
Zealand Pharma (ZEAL) Denmark $0.570B 6.35
Acorda Therapeutics (ACOR) United States $0.568B 7.36
Arcus Biosciences (RCUS) United States $0.545B 0.00
Mesoblast (MESO) Australia $0.541B 0.00
DBV Technologies (DBVT) France $0.537B 0.00
Magenta Therapeutics (MGTA) United States $0.532B 0.00
UROGEN PHARMA (URGN) United States $0.526B 0.00
Axsome Therapeutics (AXSM) United States $0.515B 0.00
Zymeworks (ZYME) Canada $0.509B 0.00
AVROBIO (AVRO) United States $0.498B 0.00
Sorrento Therapeutics (SRNE) United States $0.496B 0.00
CytomX Therapeutics (CTMX) United States $0.476B 0.00
PDL BioPharma (PDLI) United States $0.473B 10.54
ProQR Therapeutics (PRQR) Netherlands $0.468B 0.00
CYCLERION THERA (CYCN) United States $0.464B 0.00
Cytokineticsorporated (CYTK) United States $0.460B 0.00
Anika Therapeutics (ANIK) United States $0.457B 17.30
Five Prime Therapeutics (FPRX) United States $0.453B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.451B 0.00
Krystal Biotech (KRYS) United States $0.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.444B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.434B 0.00
Dynavax Technologies (DVAX) United States $0.430B 0.00
Gritstone Oncology (GRTS) United States $0.428B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.424B 0.00
MediciNova (MNOV) United States $0.421B 0.00
KALEIDO BIOSCI (KLDO) $0.420B 0.00
Scholar Rock Holding (SRRK) United States $0.414B 0.00
Albireo Pharma (ALBO) United States $0.397B 0.00
Replimune (REPL) United States $0.396B 0.00
Kezar Life Sciences (KZR) United States $0.391B 0.00
Abeona Therapeutics (ABEO) United States $0.391B 0.00
Inovio Pharmaceuticals (INO) United States $0.384B 0.00
Adverum Biotechnologies (ADVM) United States $0.375B 0.00
Merus (MRUS) Netherlands $0.375B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
STEALTH BIOTHER (MITO) United States $0.370B 0.00
Senesco Technologies (ELOX) United States $0.366B 0.00
PHASEBIO PHARMA (PHAS) United States $0.355B 0.00
Agenus (AGEN) United States $0.352B 0.00
BeyondSpring (BYSI) United States $0.345B 0.00
BioDelivery Sciences (BDSI) United States $0.344B 0.00
Kindred Biosciences (KIN) United States $0.344B 0.00
UNITY Biotechnology (UBX) $0.344B 0.00
AC Immune SA (ACIU) Switzerland $0.334B 0.00
Geron (GERN) United States $0.334B 0.00
Constellation Pharmaceuticals (CNST) United States $0.323B 0.00
Kadmon Holdings (KDMN) United States $0.320B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.319B 0.00
XBiotech (XBIT) United States $0.318B 0.00
Solid Biosciences (SLDB) United States $0.316B 0.00
Cellular Biomedicine (CBMG) United States $0.309B 0.00
MannKind (MNKD) United States $0.304B 0.00
LogicBio Therapeutics (LOGC) United States $0.296B 0.00
Aduro Biotech (ADRO) United States $0.295B 0.00
Seres Therapeutics (MCRB) United States $0.286B 0.00
Kala Pharmaceuticals (KALA) United States $0.268B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.266B 0.00
Urovant Sciences (UROV) United States $0.265B 0.00
Enochian BioSciences (ENOB) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.260B 0.00
Evelo Biosciences (EVLO) United States $0.260B 0.00
Kodiak Sciences (KOD) United States $0.259B 0.00
Novavax (NVAX) United States $0.257B 0.00
ResTORbio (TORC) United States $0.256B 0.00
Strongbridge Biopharma (SBBP) United States $0.249B 0.00
Kamada (KMDA) Israel $0.247B 11.15
Protagonist Therapeutics (PTGX) United States $0.246B 0.00
Syros Pharmaceuticals (SYRS) United States $0.241B 0.00
Avid Bioservices (CDMO) United States $0.239B 0.00
Celcuity (CELC) United States $0.235B 0.00
Palatin Technologies (PTN) United States $0.231B 114.00
Xenon Pharmaceuticals (XENE) Canada $0.228B 0.00
ADMA Biologics Inc (ADMA) United States $0.225B 0.00
Cerecor (CERC) United States $0.221B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.215B 0.00
ChromaDex (CDXC) United States $0.213B 0.00
Intec Pharma (NTEC) Israel $0.213B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
Mersana Therapeutics (MRSN) United States $0.211B 0.00
Synlogic (SYBX) United States $0.211B 0.00
OvaScience (MLND) United States $0.210B 0.00
Celyad SA (CYAD) Belgium $0.209B 0.00
TOCAGEN INC (TOCA) United States $0.208B 0.00
Athersys (ATHX) United States $0.207B 0.00
OSMOTICA PHARM (OSMT) United States $0.204B 0.00
CorMedix Inc (CRMD) United States $0.203B 0.00
VBI Vaccines (VBIV) United States $0.203B 0.00
Arbutus Biopharma (ABUS) Canada $0.201B 0.00
Gamida Cell (GMDA) Israel $0.200B 0.00
Cel-Sci (CVM) United States $0.197B 0.00
Axovant Sciences (AXGT) United Kingdom $0.193B 0.00
BioTime (BTX) United States $0.193B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
Compugen (CGEN) Israel $0.189B 0.00
Cue Biopharma (CUE) United States $0.184B 0.00
Pfenex (PFNX) United States $0.178B 0.00
Verastem (VSTM) United States $0.175B 0.00
Menlo Therapeutics (MNLO) United States $0.172B 0.00
Enzo Biochem (ENZ) United States $0.169B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
BioXcel Therapeutics (BTAI) United States $0.156B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
Liquidia Technologies (LQDA) United States $0.151B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.148B 0.00
Chiasma (CHMA) United States $0.143B 0.00
Trevena (TRVN) United States $0.141B 0.00
Allena Pharmaceuticals (ALNA) United States $0.139B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.139B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.136B 0.00
Anavex Life Sciences (AVXL) United States $0.135B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.133B 0.00
Eton Pharmaceuticals (ETON) United States $0.131B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.128B 0.00
VolitionRX (VNRX) Singapore $0.126B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
XOMA (XOMA) United States $0.115B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.114B 0.00
Cohbar (CWBR) United States $0.114B 0.00
Unum Therapeutics (UMRX) United States $0.113B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.113B 0.00
Selecta Biosciences (SELB) United States $0.112B 0.00
Neothetics (EVFM) United States $0.111B 0.00
Provention Bio (PRVB) United States $0.108B 0.00
Catalyst Biosciences (CBIO) United States $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.105B 0.00
NantKwest (NK) United States $0.104B 0.00
Checkpoint Therapeutics (CKPT) United States $0.102B 0.00
INMUNE BIO INC (INMB) United States $0.102B 0.00
Equillium (EQ) United States $0.098B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.096B 0.00
Signal Genetics (MGEN) United States $0.090B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.088B 0.00
Applied Genetic Technologies (AGTC) United States $0.086B 0.00
Cocrystal Pharma (COCP) United States $0.085B 90.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Alcobra (ARCT) United States $0.084B 0.00
Fortress Biotech (FBIO) United States $0.081B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.080B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.080B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
Mustang Bio (MBIO) United States $0.080B 0.00
Eyenovia (EYEN) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.077B 0.00
Orgenesis (ORGS) United States $0.076B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
Alimera Sciences (ALIM) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
ARAVIVE, INC (ARAV) United States $0.072B 0.00
Pluristem Therapeutics (PSTI) Israel $0.072B 0.00
AEterna Zentaris (AEZS) United States $0.072B 17.40
Cidara Therapeutics (CDTX) United States $0.071B 0.00
OVID THERAPEUTC (OVID) United States $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Curis (CRIS) United States $0.064B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Apricus Biosciences (SEEL) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.063B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.063B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Evogene (EVGN) Israel $0.060B 0.00
Ophthotech (OPHT) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.053B 0.00
ScPharmaceuticals (SCPH) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
ANCHIANO THERAP (ANCN) Israel $0.049B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.049B 0.00
AZURRX BIOPHARM (AZRX) United States $0.047B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.046B 0.00
HOTH THERAPEUTC (HOTH) United States $0.046B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.044B 0.00
Celsion (CLSN) United States $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.041B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.039B 0.00
Zosano Pharma (ZSAN) United States $0.039B 0.00
OncoSec Medical (ONCS) United States $0.039B 0.00
Leap Therapeutics (LPTX) United States $0.037B 0.00
VIVUS (VVUS) United States $0.036B 0.00
Arsanis (XFOR) United States $0.036B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
Motif Bio Plc (MTFB) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Caladrius Biosciences (CLBS) United States $0.032B 0.00
Sophiris Bio (SPHS) United States $0.031B 0.00
Adial Pharmaceuticals (ADIL) United States $0.030B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
GTx (GTXI) United States $0.027B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.027B 0.00
Moleculin Biotech (MBRX) United States $0.027B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Vical (VICL) United States $0.025B 0.00
Oragenics (OGEN) United States $0.025B 0.00
Galena Biopharma (SLS) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
TRACON Pharmaceuticals (TCON) United States $0.022B 0.00
IMMURON LTD (IMRN) Australia $0.021B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
CytRx (CYTR) United States $0.019B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
BioPharmX (BPMX) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Dare Bioscience (DARE) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.91
AmpliPhi Biosciences (APHB) United States $0.012B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
Proteon Therapeutics (PRTO) United States $0.010B 0.00
Edge Therapeutics (PDSB) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00